ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients

Brainstorm-Cell Therapeutics · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
msc
amyotrophic lateral sclerosis (als), msc, autologous, neurotrophic factors, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 859520
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.